Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.

Sci Rep · 2021 · PMC8410807 · PMID 34471171

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

showed a trendp = 0.067so close (0.05 < p ≤ 0.1)

Collagen deposition was not significantly different in the mirabegron-treated CKD group as compared to the sham-operated group; however, it showed a trend toward a decrease as compared to the CKD group (p = 0.067) (Fig. 4 e,f).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.